IL91774A0 - Preparation of plasminogen activator expressed in prokaryotes - Google Patents

Preparation of plasminogen activator expressed in prokaryotes

Info

Publication number
IL91774A0
IL91774A0 IL91774A IL9177489A IL91774A0 IL 91774 A0 IL91774 A0 IL 91774A0 IL 91774 A IL91774 A IL 91774A IL 9177489 A IL9177489 A IL 9177489A IL 91774 A0 IL91774 A0 IL 91774A0
Authority
IL
Israel
Prior art keywords
prokaryotes
preparation
plasminogen activator
activator expressed
expressed
Prior art date
Application number
IL91774A
Other languages
English (en)
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of IL91774A0 publication Critical patent/IL91774A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6456Plasminogen activators
    • C12N9/6459Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21069Protein C activated (3.4.21.69)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
IL91774A 1988-09-28 1989-09-25 Preparation of plasminogen activator expressed in prokaryotes IL91774A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3832898A DE3832898A1 (de) 1988-09-28 1988-09-28 Praeparat von in prokaryonten exprimiertem plasminogenaktivator

Publications (1)

Publication Number Publication Date
IL91774A0 true IL91774A0 (en) 1990-06-10

Family

ID=6363884

Family Applications (1)

Application Number Title Priority Date Filing Date
IL91774A IL91774A0 (en) 1988-09-28 1989-09-25 Preparation of plasminogen activator expressed in prokaryotes

Country Status (7)

Country Link
EP (1) EP0361475A1 (xx)
JP (1) JPH02503635A (xx)
AU (1) AU620927B2 (xx)
DE (1) DE3832898A1 (xx)
DK (1) DK130390D0 (xx)
IL (1) IL91774A0 (xx)
WO (1) WO1990003388A1 (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0547102B1 (en) * 1990-09-05 1998-07-08 Southern Cross Biotech Pty.Ltd. Solubilization of proteins in active forms
US5965424A (en) * 1991-01-11 1999-10-12 Boehringer Mannheim Gmbh Methods for making neisseria or hemophilus IgA protease and DNA encoding the proteases
DE4140699A1 (de) * 1991-01-11 1992-07-16 Boehringer Mannheim Gmbh Rekombinante iga-protease
US5212091A (en) * 1992-03-02 1993-05-18 Monsanto Company Method of producing tissue factor pathway inhibitor
WO1997038123A1 (en) * 1996-04-05 1997-10-16 Board Of Regents, The University Of Texas System Methods for producing soluble, biologically-active disulfide bond-containing eukaryotic proteins in bacterial cells
AU714318B2 (en) * 1996-06-11 2000-01-06 Roche Diagnostics Gmbh Process for the activation of denatured protein
US20090130714A1 (en) * 2007-09-24 2009-05-21 Reliance Life Sciences Pvt.Ltd. Process for purifying recombinanat tissue plasminogen activator (TPA)
CN103852527B (zh) * 2012-12-05 2015-05-13 中国科学院大连化学物理研究所 一种高通量蛋白质样品预处理装置

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR79124B (xx) * 1982-12-22 1984-10-02 Genentech Inc
JPS6229975A (ja) * 1985-08-01 1987-02-07 Mitsui Toatsu Chem Inc 粗tPAの精製法
JPH0672105B2 (ja) * 1985-10-02 1994-09-14 持田製薬株式会社 血栓溶解剤及びその製法
DE3537708A1 (de) * 1985-10-23 1987-04-23 Boehringer Mannheim Gmbh Verfahren zur aktivierung von t-pa nach expression in prokaryonten
FR2594845B1 (fr) * 1986-02-21 1989-12-01 Genetica Preparation par voie microbiologique de l'activateur tissulaire humain du plasminogene (t-pa) et conversion de l'enzyme ainsi obtenue en sa forme active
DE3611817A1 (de) * 1986-04-08 1987-10-15 Boehringer Mannheim Gmbh Verfahren zur renaturierung von proteinen
DE3613401A1 (de) * 1986-04-21 1987-12-17 Boehringer Mannheim Gmbh Verfahren zur herstellung von plasminogen-aktivatoren in prokaryonten
DE3643158A1 (de) * 1986-04-21 1987-11-19 Boehringer Mannheim Gmbh Gewebs-plasminogen-aktivator(tpa) - derivat und seine herstellung
US4898825A (en) * 1986-05-07 1990-02-06 Mitsui Toatsu Chemicals, Incorporated Methods for purification of single-chain and double-chain tissue plasminogen activator
JPH0779692B2 (ja) * 1986-05-07 1995-08-30 三井東圧化学株式会社 一本鎖t−PAと二本鎖t−PAを分離する方法
AU7709287A (en) * 1986-07-16 1988-02-10 Celltech Limited Process for purifying a plasminogen activator

Also Published As

Publication number Publication date
EP0361475A1 (de) 1990-04-04
AU4338589A (en) 1990-04-18
DK130390A (da) 1990-05-25
JPH02503635A (ja) 1990-11-01
DK130390D0 (da) 1990-05-25
DE3832898A1 (de) 1990-04-12
AU620927B2 (en) 1992-02-27
WO1990003388A1 (de) 1990-04-05

Similar Documents

Publication Publication Date Title
GB2221390B (en) Niacin-containing composition and its therapeutic use
IL78938A0 (en) Pharmaceutical composition containing tissue plasminogen activator and its preparation
NZ216306A (en) Pharmaceutical compositions containing tissue plasminogen activator
AU6806487A (en) Tissue plasminogen activator
IL82272A0 (en) Tissue-type plasminogen activator and process for preparation thereof
IL91774A0 (en) Preparation of plasminogen activator expressed in prokaryotes
GB8911294D0 (en) Composition and use
NZ217331A (en) Tissue plasminogen activator derivatives and genetically engineered product
AU4539389A (en) Improvements in and/or relating to crib walls
IL90745A0 (en) Tissue plasminogen activator analogue and nucleic acid coding for it
ZA863956B (en) Pharmaceutical formulations containing tissue plasminogen activator
AU3406389A (en) Synergistic combinations of beta-mimetic compounds and PAF-antagonists and their use as therapeutic agents
EP0337817A3 (en) Plasminogen activator and thrombolytic agent
IL78450A0 (en) Agent containing tissue plasminogen activator(t-pa)
IE883342L (en) Human tissue-type plasminogen activator variant
AU7090787A (en) Tissue plasminogen activator
GB8815245D0 (en) New tissue plasminogen activator
GB8826692D0 (en) Tissue plasminogen activator
IE872091L (en) Combination of tissue plasminogen activator and a¹prostaglandin
IE882534L (en) Peg complex of tissue plasminogen activator
NZ223291A (en) Modified tissue-type plasminogen activator
GB8815246D0 (en) New tissue plasminogen activator
GB8815247D0 (en) New tissue plasminogen activator
ZA862976B (en) Human tissue plasminogen activator mutants
GB8810369D0 (en) Improvements in use of solid-fuels